U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Poitras V, Wells C, Hutnik C, et al. Optimal Use of Minimally Invasive Glaucoma Surgery: A Health Technology Assessment [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jan. (CADTH Optimal Use Report, No. 8.1b.)

Cover of Optimal Use of Minimally Invasive Glaucoma Surgery: A Health Technology Assessment

Optimal Use of Minimally Invasive Glaucoma Surgery: A Health Technology Assessment [Internet].

Show details

Appendix 16Incremental Cost-Effectiveness Planes

Figure 29. Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 1 — Reference Case (Alberta Perspective).

Figure 29Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 1 — Reference Case (Alberta Perspective)

WTP = willingness-to-pay.

Figure 30. Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 1 — Ontario Perspective.

Figure 30Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 1 — Ontario Perspective

WTP = willingness-to-pay.

Figure 31. Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 2 — Reference Case (Alberta Perspective).

Figure 31Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 2 — Reference Case (Alberta Perspective)

WTP = willingness-to-pay.

Figure 32. Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 2 — Ontario Perspective.

Figure 32Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 2 — Ontario Perspective

WTP = willingness-to-pay.

Figure 33. Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 3a — Reference Case (Alberta Perspective), Based on Trabectome.

Figure 33Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 3a — Reference Case (Alberta Perspective), Based on Trabectome

WTP = willingness-to-pay.

Figure 34. Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 3a — Ontario Perspective, Based on Trabectome.

Figure 34Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 3a — Ontario Perspective, Based on Trabectome

WTP = willingness-to-pay.

Figure 35. Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 3a — Reference Case (Alberta Perspective), Based on iStent Inject.

Figure 35Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 3a — Reference Case (Alberta Perspective), Based on iStent Inject

Figure 36. Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 3a — Reference Case (Alberta Perspective), Based on XEN 45.

Figure 36Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 3a — Reference Case (Alberta Perspective), Based on XEN 45

Note: Effectiveness parameters were not defined by a distribution.

Figure 37. Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 3b — Reference Case (Alberta Perspective).

Figure 37Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 3b — Reference Case (Alberta Perspective)

WTP = willingness-to-pay.

Figure 38. Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 3b — Ontario Perspective.

Figure 38Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 3b — Ontario Perspective

WTP = willingness-to-pay.

Figure 39. Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 4 — Reference Case (Alberta Perspective), Based on Hydrus Microstent + Cataract Surgery.

Figure 39Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 4 — Reference Case (Alberta Perspective), Based on Hydrus Microstent + Cataract Surgery

WTP = willingness-to-pay.

Figure 40. Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 4 — Ontario Perspective, Based on Hydrus Microstent + Cataract Surgery.

Figure 40Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 4 — Ontario Perspective, Based on Hydrus Microstent + Cataract Surgery

WTP = willingness-to-pay.

Figure 41. Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 4 — Reference Case (Alberta Perspective), Based on iStent Inject+ Cataract Surgery.

Figure 41Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 4 — Reference Case (Alberta Perspective), Based on iStent Inject+ Cataract Surgery

WTP = willingness-to-pay.

Figure 42. Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 4 — Reference Case (Alberta Perspective), Based on CyPass Micro-Stent + Cataract Surgery.

Figure 42Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 4 — Reference Case (Alberta Perspective), Based on CyPass Micro-Stent + Cataract Surgery

WTP = willingness-to-pay.

Figure 43. Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 4 — Reference Case (Alberta Perspective), Based on ECP + Cataract Surgery.

Figure 43Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 4 — Reference Case (Alberta Perspective), Based on ECP + Cataract Surgery

ECP = endoscopic cyclophotocoagulation; WTP = willingness-to-pay.

Figure 44. Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 5 — Reference Case (Alberta Perspective).

Figure 44Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 5 — Reference Case (Alberta Perspective)

WTP = willingness-to-pay.

Figure 45. Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 5 — Ontario Perspective.

Figure 45Probabilistic Results on the Incremental Cost-Effectiveness Plane for Model 5 — Ontario Perspective

WTP = willingness-to-pay.

Copyright © 2019 Canadian Agency for Drugs and Technologies in Health.

Copyright © CADTH. This report may be reproduced for non-commercial purposes only and provided that appropriate credit is given to CADTH.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

Bookshelf ID: NBK543899
Contents

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (8.2M)

Other titles in this collection

Recent Activity

ClearTurn OffTurn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...